Cathepsin K Is the Principal Protease in Giant Cell Tumor of Bone

Giant cell tumor (GCT) of bone is a neoplasm of bone characterized by a localized osteolytic lesion. The nature of GCT is an enigma and the cell type(s) and protease(s) responsible for the extensive localized clinicoradiological osteolysis remain unresolved. We evaluated protease expression and cell...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of pathology 2004-08, Vol.165 (2), p.593-600
Hauptverfasser: Lindeman, Jan H.N., Hanemaaijer, Roeland, Mulder, Adri, Dijkstra, P.D. Sander, Szuhai, Károly, Bromme, Dieter, Verheijen, Jan H., Hogendoorn, Pancras C.W.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 600
container_issue 2
container_start_page 593
container_title The American journal of pathology
container_volume 165
creator Lindeman, Jan H.N.
Hanemaaijer, Roeland
Mulder, Adri
Dijkstra, P.D. Sander
Szuhai, Károly
Bromme, Dieter
Verheijen, Jan H.
Hogendoorn, Pancras C.W.
description Giant cell tumor (GCT) of bone is a neoplasm of bone characterized by a localized osteolytic lesion. The nature of GCT is an enigma and the cell type(s) and protease(s) responsible for the extensive localized clinicoradiological osteolysis remain unresolved. We evaluated protease expression and cellular distribution of the proteolytic machinery responsible for the osteolysis. mRNA profiles showed that cathepsin K, cathepsin L, and matrix metalloproteinase (MMP)-9 were the preferentially expressed collagenases. Moderate expression was found for MMP-13, MMP-14, and cathepsin S. Specific protease activity assays revealed high cathepsin K activity but showed that MMP-9 was primarily present (98%) as inactive proenzyme. Activities of MMP-13 and MMP-14 were low. Immunohistochemistry revealed a clear spatial distribution: cathepsin K, its associated proton pump V-H +-ATPase, and MMP-9 were exclusively expressed in osteoclast-like giant cells, whereas cathepsin L expression was confined to mononuclear cells. To explore a possible role of cathepsin L in osteolysis, GCT-derived, cathepsin L-expressing, mononuclear cells were cultured on dentine disks. No evidence of osteolysis by these cells was found. These results implicate cathepsin K as the principal protease in GCT and suggest that osteoclast-like giant cells are responsible for the osteolysis. Inhibition of cathepsin K or its associated proton-pump may provide new therapeutic opportunities for GCT.
doi_str_mv 10.1016/S0002-9440(10)63323-8
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1618565</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002944010633238</els_id><sourcerecordid>66746488</sourcerecordid><originalsourceid>FETCH-LOGICAL-c642t-516be1bd6989bd56f75012f189b5a92642edd09311877ce0531df9aeb749347e3</originalsourceid><addsrcrecordid>eNqFkEFvFCEUx4nR2LX6ETRcNHoY5cEAw0VTN1obm2hiPROGedOlmRlGmK3x28t2N209eYIHv_fn8SPkObC3wEC9-8EY45Wpa_Ya2BslBBdV84CsQHJZcTDwkKxukSPyJOerUirRsMfkqEBac8FX5GTtlg3OOUz0Kz3LtBT0ewqTD7Mbyi4u6DLScn0a3LTQNQ4DvdiOMdHY049xwqfkUe-GjM8O6zH5-fnTxfpLdf7t9Gx9cl55VfOlkqBahLZTpjFtJ1WvJQPeQ6mkM7ww2HXMCIBGa49MCuh647DVtRG1RnFM3u9z5207YudxWpIb7JzC6NIfG12w_95MYWMv47UFBY1UsgS8OgSk-GuLebFjyL78x00Yt9kqpWtVN00B5R70KeacsL99BJjdybc38u3O7O7oRr7d9b24P-Fd18F2AV4eAJe9G_rkiud8jzO6oHA36SZcbn6HhDaPbhhKLFh3NYOSlltpRAE_7EEs4q8DJpt9wMljV5r8YrsY_jPzX_g8rKI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>66746488</pqid></control><display><type>article</type><title>Cathepsin K Is the Principal Protease in Giant Cell Tumor of Bone</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Lindeman, Jan H.N. ; Hanemaaijer, Roeland ; Mulder, Adri ; Dijkstra, P.D. Sander ; Szuhai, Károly ; Bromme, Dieter ; Verheijen, Jan H. ; Hogendoorn, Pancras C.W.</creator><creatorcontrib>Lindeman, Jan H.N. ; Hanemaaijer, Roeland ; Mulder, Adri ; Dijkstra, P.D. Sander ; Szuhai, Károly ; Bromme, Dieter ; Verheijen, Jan H. ; Hogendoorn, Pancras C.W.</creatorcontrib><description>Giant cell tumor (GCT) of bone is a neoplasm of bone characterized by a localized osteolytic lesion. The nature of GCT is an enigma and the cell type(s) and protease(s) responsible for the extensive localized clinicoradiological osteolysis remain unresolved. We evaluated protease expression and cellular distribution of the proteolytic machinery responsible for the osteolysis. mRNA profiles showed that cathepsin K, cathepsin L, and matrix metalloproteinase (MMP)-9 were the preferentially expressed collagenases. Moderate expression was found for MMP-13, MMP-14, and cathepsin S. Specific protease activity assays revealed high cathepsin K activity but showed that MMP-9 was primarily present (98%) as inactive proenzyme. Activities of MMP-13 and MMP-14 were low. Immunohistochemistry revealed a clear spatial distribution: cathepsin K, its associated proton pump V-H +-ATPase, and MMP-9 were exclusively expressed in osteoclast-like giant cells, whereas cathepsin L expression was confined to mononuclear cells. To explore a possible role of cathepsin L in osteolysis, GCT-derived, cathepsin L-expressing, mononuclear cells were cultured on dentine disks. No evidence of osteolysis by these cells was found. These results implicate cathepsin K as the principal protease in GCT and suggest that osteoclast-like giant cells are responsible for the osteolysis. Inhibition of cathepsin K or its associated proton-pump may provide new therapeutic opportunities for GCT.</description><identifier>ISSN: 0002-9440</identifier><identifier>EISSN: 1525-2191</identifier><identifier>DOI: 10.1016/S0002-9440(10)63323-8</identifier><identifier>PMID: 15277232</identifier><identifier>CODEN: AJPAA4</identifier><language>eng</language><publisher>Bethesda, MD: Elsevier Inc</publisher><subject>Adult ; Biological and medical sciences ; Bone Neoplasms - enzymology ; Bone Neoplasms - pathology ; Cathepsin K ; Cathepsin L ; Cathepsins - metabolism ; Collagenases - metabolism ; Cysteine Endopeptidases - metabolism ; Female ; Giant Cell Tumor of Bone - enzymology ; Giant Cell Tumor of Bone - pathology ; Humans ; Immunoenzyme Techniques ; Investigative techniques, diagnostic techniques (general aspects) ; Male ; Matrix Metalloproteinase 13 ; Matrix Metalloproteinases, Membrane-Associated ; Medical sciences ; Metalloendopeptidases - metabolism ; Middle Aged ; Osteoclasts - metabolism ; Osteoclasts - pathology ; Osteolysis - enzymology ; Osteolysis - pathology ; Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques ; Regular ; RNA, Messenger - metabolism</subject><ispartof>The American journal of pathology, 2004-08, Vol.165 (2), p.593-600</ispartof><rights>2004 American Society for Investigative Pathology</rights><rights>2004 INIST-CNRS</rights><rights>Copyright © American Society for Investigative Pathology 2004</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c642t-516be1bd6989bd56f75012f189b5a92642edd09311877ce0531df9aeb749347e3</citedby><cites>FETCH-LOGICAL-c642t-516be1bd6989bd56f75012f189b5a92642edd09311877ce0531df9aeb749347e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1618565/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0002944010633238$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,3537,27901,27902,53766,53768,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15975271$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15277232$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lindeman, Jan H.N.</creatorcontrib><creatorcontrib>Hanemaaijer, Roeland</creatorcontrib><creatorcontrib>Mulder, Adri</creatorcontrib><creatorcontrib>Dijkstra, P.D. Sander</creatorcontrib><creatorcontrib>Szuhai, Károly</creatorcontrib><creatorcontrib>Bromme, Dieter</creatorcontrib><creatorcontrib>Verheijen, Jan H.</creatorcontrib><creatorcontrib>Hogendoorn, Pancras C.W.</creatorcontrib><title>Cathepsin K Is the Principal Protease in Giant Cell Tumor of Bone</title><title>The American journal of pathology</title><addtitle>Am J Pathol</addtitle><description>Giant cell tumor (GCT) of bone is a neoplasm of bone characterized by a localized osteolytic lesion. The nature of GCT is an enigma and the cell type(s) and protease(s) responsible for the extensive localized clinicoradiological osteolysis remain unresolved. We evaluated protease expression and cellular distribution of the proteolytic machinery responsible for the osteolysis. mRNA profiles showed that cathepsin K, cathepsin L, and matrix metalloproteinase (MMP)-9 were the preferentially expressed collagenases. Moderate expression was found for MMP-13, MMP-14, and cathepsin S. Specific protease activity assays revealed high cathepsin K activity but showed that MMP-9 was primarily present (98%) as inactive proenzyme. Activities of MMP-13 and MMP-14 were low. Immunohistochemistry revealed a clear spatial distribution: cathepsin K, its associated proton pump V-H +-ATPase, and MMP-9 were exclusively expressed in osteoclast-like giant cells, whereas cathepsin L expression was confined to mononuclear cells. To explore a possible role of cathepsin L in osteolysis, GCT-derived, cathepsin L-expressing, mononuclear cells were cultured on dentine disks. No evidence of osteolysis by these cells was found. These results implicate cathepsin K as the principal protease in GCT and suggest that osteoclast-like giant cells are responsible for the osteolysis. Inhibition of cathepsin K or its associated proton-pump may provide new therapeutic opportunities for GCT.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Bone Neoplasms - enzymology</subject><subject>Bone Neoplasms - pathology</subject><subject>Cathepsin K</subject><subject>Cathepsin L</subject><subject>Cathepsins - metabolism</subject><subject>Collagenases - metabolism</subject><subject>Cysteine Endopeptidases - metabolism</subject><subject>Female</subject><subject>Giant Cell Tumor of Bone - enzymology</subject><subject>Giant Cell Tumor of Bone - pathology</subject><subject>Humans</subject><subject>Immunoenzyme Techniques</subject><subject>Investigative techniques, diagnostic techniques (general aspects)</subject><subject>Male</subject><subject>Matrix Metalloproteinase 13</subject><subject>Matrix Metalloproteinases, Membrane-Associated</subject><subject>Medical sciences</subject><subject>Metalloendopeptidases - metabolism</subject><subject>Middle Aged</subject><subject>Osteoclasts - metabolism</subject><subject>Osteoclasts - pathology</subject><subject>Osteolysis - enzymology</subject><subject>Osteolysis - pathology</subject><subject>Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques</subject><subject>Regular</subject><subject>RNA, Messenger - metabolism</subject><issn>0002-9440</issn><issn>1525-2191</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkEFvFCEUx4nR2LX6ETRcNHoY5cEAw0VTN1obm2hiPROGedOlmRlGmK3x28t2N209eYIHv_fn8SPkObC3wEC9-8EY45Wpa_Ya2BslBBdV84CsQHJZcTDwkKxukSPyJOerUirRsMfkqEBac8FX5GTtlg3OOUz0Kz3LtBT0ewqTD7Mbyi4u6DLScn0a3LTQNQ4DvdiOMdHY049xwqfkUe-GjM8O6zH5-fnTxfpLdf7t9Gx9cl55VfOlkqBahLZTpjFtJ1WvJQPeQ6mkM7ww2HXMCIBGa49MCuh647DVtRG1RnFM3u9z5207YudxWpIb7JzC6NIfG12w_95MYWMv47UFBY1UsgS8OgSk-GuLebFjyL78x00Yt9kqpWtVN00B5R70KeacsL99BJjdybc38u3O7O7oRr7d9b24P-Fd18F2AV4eAJe9G_rkiud8jzO6oHA36SZcbn6HhDaPbhhKLFh3NYOSlltpRAE_7EEs4q8DJpt9wMljV5r8YrsY_jPzX_g8rKI</recordid><startdate>20040801</startdate><enddate>20040801</enddate><creator>Lindeman, Jan H.N.</creator><creator>Hanemaaijer, Roeland</creator><creator>Mulder, Adri</creator><creator>Dijkstra, P.D. Sander</creator><creator>Szuhai, Károly</creator><creator>Bromme, Dieter</creator><creator>Verheijen, Jan H.</creator><creator>Hogendoorn, Pancras C.W.</creator><general>Elsevier Inc</general><general>ASIP</general><general>American Society for Investigative Pathology</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20040801</creationdate><title>Cathepsin K Is the Principal Protease in Giant Cell Tumor of Bone</title><author>Lindeman, Jan H.N. ; Hanemaaijer, Roeland ; Mulder, Adri ; Dijkstra, P.D. Sander ; Szuhai, Károly ; Bromme, Dieter ; Verheijen, Jan H. ; Hogendoorn, Pancras C.W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c642t-516be1bd6989bd56f75012f189b5a92642edd09311877ce0531df9aeb749347e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Bone Neoplasms - enzymology</topic><topic>Bone Neoplasms - pathology</topic><topic>Cathepsin K</topic><topic>Cathepsin L</topic><topic>Cathepsins - metabolism</topic><topic>Collagenases - metabolism</topic><topic>Cysteine Endopeptidases - metabolism</topic><topic>Female</topic><topic>Giant Cell Tumor of Bone - enzymology</topic><topic>Giant Cell Tumor of Bone - pathology</topic><topic>Humans</topic><topic>Immunoenzyme Techniques</topic><topic>Investigative techniques, diagnostic techniques (general aspects)</topic><topic>Male</topic><topic>Matrix Metalloproteinase 13</topic><topic>Matrix Metalloproteinases, Membrane-Associated</topic><topic>Medical sciences</topic><topic>Metalloendopeptidases - metabolism</topic><topic>Middle Aged</topic><topic>Osteoclasts - metabolism</topic><topic>Osteoclasts - pathology</topic><topic>Osteolysis - enzymology</topic><topic>Osteolysis - pathology</topic><topic>Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques</topic><topic>Regular</topic><topic>RNA, Messenger - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lindeman, Jan H.N.</creatorcontrib><creatorcontrib>Hanemaaijer, Roeland</creatorcontrib><creatorcontrib>Mulder, Adri</creatorcontrib><creatorcontrib>Dijkstra, P.D. Sander</creatorcontrib><creatorcontrib>Szuhai, Károly</creatorcontrib><creatorcontrib>Bromme, Dieter</creatorcontrib><creatorcontrib>Verheijen, Jan H.</creatorcontrib><creatorcontrib>Hogendoorn, Pancras C.W.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The American journal of pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lindeman, Jan H.N.</au><au>Hanemaaijer, Roeland</au><au>Mulder, Adri</au><au>Dijkstra, P.D. Sander</au><au>Szuhai, Károly</au><au>Bromme, Dieter</au><au>Verheijen, Jan H.</au><au>Hogendoorn, Pancras C.W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cathepsin K Is the Principal Protease in Giant Cell Tumor of Bone</atitle><jtitle>The American journal of pathology</jtitle><addtitle>Am J Pathol</addtitle><date>2004-08-01</date><risdate>2004</risdate><volume>165</volume><issue>2</issue><spage>593</spage><epage>600</epage><pages>593-600</pages><issn>0002-9440</issn><eissn>1525-2191</eissn><coden>AJPAA4</coden><abstract>Giant cell tumor (GCT) of bone is a neoplasm of bone characterized by a localized osteolytic lesion. The nature of GCT is an enigma and the cell type(s) and protease(s) responsible for the extensive localized clinicoradiological osteolysis remain unresolved. We evaluated protease expression and cellular distribution of the proteolytic machinery responsible for the osteolysis. mRNA profiles showed that cathepsin K, cathepsin L, and matrix metalloproteinase (MMP)-9 were the preferentially expressed collagenases. Moderate expression was found for MMP-13, MMP-14, and cathepsin S. Specific protease activity assays revealed high cathepsin K activity but showed that MMP-9 was primarily present (98%) as inactive proenzyme. Activities of MMP-13 and MMP-14 were low. Immunohistochemistry revealed a clear spatial distribution: cathepsin K, its associated proton pump V-H +-ATPase, and MMP-9 were exclusively expressed in osteoclast-like giant cells, whereas cathepsin L expression was confined to mononuclear cells. To explore a possible role of cathepsin L in osteolysis, GCT-derived, cathepsin L-expressing, mononuclear cells were cultured on dentine disks. No evidence of osteolysis by these cells was found. These results implicate cathepsin K as the principal protease in GCT and suggest that osteoclast-like giant cells are responsible for the osteolysis. Inhibition of cathepsin K or its associated proton-pump may provide new therapeutic opportunities for GCT.</abstract><cop>Bethesda, MD</cop><pub>Elsevier Inc</pub><pmid>15277232</pmid><doi>10.1016/S0002-9440(10)63323-8</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0002-9440
ispartof The American journal of pathology, 2004-08, Vol.165 (2), p.593-600
issn 0002-9440
1525-2191
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1618565
source MEDLINE; Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects Adult
Biological and medical sciences
Bone Neoplasms - enzymology
Bone Neoplasms - pathology
Cathepsin K
Cathepsin L
Cathepsins - metabolism
Collagenases - metabolism
Cysteine Endopeptidases - metabolism
Female
Giant Cell Tumor of Bone - enzymology
Giant Cell Tumor of Bone - pathology
Humans
Immunoenzyme Techniques
Investigative techniques, diagnostic techniques (general aspects)
Male
Matrix Metalloproteinase 13
Matrix Metalloproteinases, Membrane-Associated
Medical sciences
Metalloendopeptidases - metabolism
Middle Aged
Osteoclasts - metabolism
Osteoclasts - pathology
Osteolysis - enzymology
Osteolysis - pathology
Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques
Regular
RNA, Messenger - metabolism
title Cathepsin K Is the Principal Protease in Giant Cell Tumor of Bone
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T01%3A18%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cathepsin%20K%20Is%20the%20Principal%20Protease%20in%20Giant%20Cell%20Tumor%20of%20Bone&rft.jtitle=The%20American%20journal%20of%20pathology&rft.au=Lindeman,%20Jan%20H.N.&rft.date=2004-08-01&rft.volume=165&rft.issue=2&rft.spage=593&rft.epage=600&rft.pages=593-600&rft.issn=0002-9440&rft.eissn=1525-2191&rft.coden=AJPAA4&rft_id=info:doi/10.1016/S0002-9440(10)63323-8&rft_dat=%3Cproquest_pubme%3E66746488%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=66746488&rft_id=info:pmid/15277232&rft_els_id=S0002944010633238&rfr_iscdi=true